IMA · ImageneBio Inc
United States · RS rating 17 · As of 2026-11-03
| Price | 4.02 USD |
|---|---|
| 1-day change | -1.7% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 28 / 21 / 20 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 7 / 32 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +33.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +53.3% |
| Market cap (USD) | $65.5M |